Company intelligence / Profile preview

Renewal Bio

Nes Ziona, Central District, Israelrenewal.bio ↗

Ownership: Private
Development stage: Preclinical

Overview

The company is developing novel cell replacement therapy solutions for human regenerative medicine and fertility. They have published research on ex utero mouse embryogenesis and synthetic embryos generated from mouse naïve ESCs, as well as complete human day 14 post-implantation embryo models from naïve ES cells.

Modalities: Cell therapyregenerative medicinetissue engineering
Industry: Biotech

Beyond the preview

Go deeper on Renewal Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renewal Bio.

Explore the full profile